| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
disease | 0.100 | None | 0.967 | 58 | 0 | 1979 | 2019 | ||||||||
|
glucose-6-phosphate dehydrogenase | 0.424 | 0.846 | 0.97 |
|
disease | 0.100 | None | 1.000 | 11 | 0 | 1979 | 2017 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.090 | None | 1.000 | 9 | 0 | 1979 | 2019 | ||||||||
|
modulator of VRAC current 1 | 0.585 | 0.769 | 3.2E-08 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1980 | 2011 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.100 | None | 0.923 | 13 | 0 | 1981 | 2020 | ||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
disease | 0.400 | strong | 0.958 | 143 | 0 | 1982 | 2020 | ||||||||
|
lamin B receptor | 0.473 | 0.808 | 0.18 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1982 | 1985 | ||||||||
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
disease | 0.700 | None | 0.987 | 70 | 2 | 1984 | 2019 | ||||||||
|
colony stimulating factor 2 | 0.330 | 0.962 | 0.83 |
|
disease | 0.400 | None | 0.985 | 65 | 0 | 1985 | 2019 | ||||||||
|
MOS proto-oncogene, serine/threonine kinase | 0.617 | 0.500 | 0.59 |
|
disease | 0.050 | None | 0.600 | 5 | 0 | 1985 | 1989 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.700 | None | 0.961 | 224 | 10 | 1986 | 2020 | ||||||||
|
ETS proto-oncogene 2, transcription factor | 0.548 | 0.808 | 1.00 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 1986 | 2017 | ||||||||
|
colony stimulating factor 3 | 0.377 | 0.885 | 0.38 |
|
disease | 0.400 | None | 0.970 | 100 | 0 | 1987 | 2020 | ||||||||
|
myeloperoxidase | 0.377 | 0.923 | 7.1E-15 |
|
disease | 0.100 | None | 0.979 | 46 | 0 | 1987 | 2019 | ||||||||
|
interleukin 3 | 0.489 | 0.731 | 2.6E-09 |
|
disease | 0.100 | None | 0.977 | 44 | 0 | 1987 | 2019 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
disease | 0.100 | None | 0.964 | 27 | 1 | 1987 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.700 | None | 0.939 | 24 | 2 | 1987 | 2020 | ||||||||
|
interleukin 2 receptor subunit alpha | 0.389 | 0.885 | 5.5E-02 |
|
disease | 0.100 | None | 0.950 | 20 | 0 | 1987 | 2019 | ||||||||
|
interferon stimulated exonuclease gene 20 | 0.414 | 0.846 | 2.9E-03 |
|
disease | 0.100 | None | 0.941 | 17 | 0 | 1987 | 2019 | ||||||||
|
interleukin 1 alpha | 0.333 | 0.962 | 1.6E-04 |
|
disease | 0.100 | None | 0.938 | 16 | 0 | 1987 | 2018 | ||||||||
|
T cell receptor beta variable 20/OR9-2 (non-functional) | 0.403 | 0.923 |
|
disease | 0.100 | None | 0.933 | 15 | 0 | 1987 | 2019 | |||||||||
|
colony stimulating factor 1 | 0.473 | 0.808 | 1.00 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 1987 | 2019 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
disease | 0.500 | None | 0.833 | 9 | 2 | 1987 | 2016 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 1987 | 2016 | ||||||||
|
calcitonin related polypeptide alpha | 0.416 | 0.923 | 1.6E-02 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 1987 | 2019 |